Thall, P. F., Garrett-Mayer, E., Wages, N. A., Halabi, S., & Cheung, Y. K. (2024). Current issues in dose-finding designs: A response to the US Food and Drug Adminstration’s Oncology Center of Excellence Project Optimus. Clinical Trials, 21(3), 267–272. https://doi.org/10.1177/17407745241234652

Biard, L., Andrillon, A., Silva, R. B., & Lee, S. M. (2024). Dose optimization for cancer treatments with considerations for late-onset toxicities. Clinical Trials, 21(3), 322–330. https://doi.org/10.1177/17407745231221152

Maués, J., Loeser, A., Cowden, J., Johnson, S., Carlson, M., & Lee, S. (2024). The patient perspective on dose optimization for anticancer treatments: A new era of cancer drug dosing—Challenging the “more is better” dogma. Clinical Trials, 21(3), 358–362. https://doi.org/10.1177/17407745241232428

Ironside, N., Patrie, J., Ng, S., Ding, D., Rizvi, T., Kumar, J. S., Mastorakos, P., Hussein, M. Z., Naamani, K. E., Abbas, R., Harrison Snyder, M., Zhuang, Y., Kearns, K. N., Doan, K. T., Shabo, L. M., Marfatiah, S., Roh, D., Lignelli-Dipple, A., Claassen, J., … Chen, C.-J. (2022). Quantification of hematoma and perihematomal edema volumes in intracerebral hemorrhage study: Design considerations in an artificial intelligence validation (QUANTUM) study. Clinical Trials, 19(5), 534–544. https://doi.org/10.1177/17407745221105886